Autopsy report · NCT00727207

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

“Lack of participations (8 of 25)”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 6 years 4 months before it stopped.
• 35 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Technical University of Munich

Sponsor type

University, hospital or other

Conditions

Lymphoma

Interventions

everolimus

Participants

35 (planned, not actual)

Sites

1

Countries

Germany

Trials that died the same way

• The Effect of Wound Edge Eversion on Cosmesis
  “lack of participation” (86% match in meaning)
• Evaluation of Proprioception in Patients With Total Hip Replacement
  “lack of participants” (77% match in meaning)
• Physiotherapy and Therapeutic Education After Total Knee Arthroplasty.
  “low participation” (76% match in meaning)
• Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia
  “lack of eligible participants” (74% match in meaning)
• Project 1: ACHIEVE- HTN
  “Due lack of eligible participants” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.